Epithelial–mesenchymal transition inhibition by metformin reduces melanoma lung metastasis in a murine model
| dc.creator | Emerson Soares Veloso | |
| dc.creator | Helen Lima Del Puerto | |
| dc.creator | Enio Ferreira | |
| dc.creator | Bárbara Andrade de Carvalho | |
| dc.creator | Felipe Henrique de Souza Silva | |
| dc.creator | Thaís Salviana Ribeiro | |
| dc.creator | Bruna Mendes Lima | |
| dc.creator | Camila Pereira Almeida | |
| dc.creator | Vítor Henrique Soares Romão da Silva | |
| dc.creator | Sara Aparecida Rocha | |
| dc.creator | Marina Rios de Araújo Campos | |
| dc.date.accessioned | 2023-10-31T21:36:30Z | |
| dc.date.accessioned | 2025-09-09T00:57:56Z | |
| dc.date.available | 2023-10-31T21:36:30Z | |
| dc.date.issued | 2022-10-22 | |
| dc.description.sponsorship | CNPq - Conselho Nacional de Desenvolvimento Científico e Tecnológico | |
| dc.description.sponsorship | FAPEMIG - Fundação de Amparo à Pesquisa do Estado de Minas Gerais | |
| dc.description.sponsorship | CAPES - Coordenação de Aperfeiçoamento de Pessoal de Nível Superior | |
| dc.format.mimetype | ||
| dc.identifier.doi | https://doi.org/10.1038/s41598-022-22235-8 | |
| dc.identifier.issn | 2045-2322 | |
| dc.identifier.uri | https://hdl.handle.net/1843/60398 | |
| dc.language | eng | |
| dc.publisher | Universidade Federal de Minas Gerais | |
| dc.relation.ispartof | Scientific Reports | |
| dc.rights | Acesso Aberto | |
| dc.subject | Metástase | |
| dc.subject | Tumores | |
| dc.subject | Melanoma | |
| dc.subject.other | Metástase | |
| dc.subject.other | Tumores | |
| dc.subject.other | Melanoma | |
| dc.title | Epithelial–mesenchymal transition inhibition by metformin reduces melanoma lung metastasis in a murine model | |
| dc.type | Artigo de periódico | |
| local.citation.epage | 13 | |
| local.citation.issue | 1 | |
| local.citation.spage | 17776 | |
| local.citation.volume | 12 | |
| local.description.resumo | Melanoma is an aggressive cancer with fast metastatic spread and reduced survival time. One common event during the neoplastic progression is the epithelial–mesenchymal transition (EMT), which enhances invasiveness, cell migration, and metastasis. In this study, we investigated the effects of metformin at EMT in melanoma cell lines B16-F10 and A-375, in vitro, and the impact of EMT downregulation on melanoma progression in vivo. The metformin cells treatment reduces the migration potential in vitro and reduced the development of pulmonary metastases and the expressions of N-cadherin, vimentin, ZEB1, and ZEB2 at the metastases site, in vivo. These results indicate that metformin can promote EMT downregulation impairing the metastatic potential of melanoma cells. | |
| local.identifier.orcid | https://orcid.org/0000-0002-1835-0303 | |
| local.publisher.country | Brasil | |
| local.publisher.department | ICB - DEPARTAMENTO DE PATOLOGIA | |
| local.publisher.department | ICB - INSTITUTO DE CIÊNCIAS BIOLOGICAS | |
| local.publisher.initials | UFMG | |
| local.url.externa | https://www.nature.com/articles/s41598-022-22235-8#rightslink |
Arquivos
Pacote original
1 - 1 de 1
Carregando...
- Nome:
- Epithelial–mesenchymal transition inhibition by metformin reduces melanoma lung metastasis in a murine model.pdf
- Tamanho:
- 2.91 MB
- Formato:
- Adobe Portable Document Format
Licença do pacote
1 - 1 de 1